XML 59 R45.htm IDEA: XBRL DOCUMENT v3.25.3
SHARE-BASED COMPENSATION (Tables)
 12 Months Ended
Oct. 31, 2025
SHARE-BASED COMPENSATION [Abstract]  
Share-based Compensation Expenses
The table below presents information on the Company’s share-based compensation expenses for the three most recent fiscal years.

   
Year Ended
  
   
October 31,
    
October 31,
    
October 31,
  
   
2025
    
2024
    
2023
  
Expense reported in:
                  
Cost of goods sold
  
$
3,233
    
$
2,704
    
$
1,259
  
Selling, general, and administrative
    
8,954
      
10,124
      
5,962
  
Research and development
    
1,201
      
1,062
      
780
  
Total expense incurred
  
$
13,388
    
$
13,890
    
$
8,001
  
                         
Expense by award type:
                        
Restricted stock awards *
  
$
11,966
    
$
13,868
    
$
7,909
  
Restricted stock units
    
1,216
      
-
      
-
  
Stock options
    
-
      
-
      
1
  
Employee stock purchase plan
    
206
      
22
      
91
  
Total expense incurred
  
$
13,388
    
$
13,890
    
$
8,001
  
                         
Income tax benefits of share-based compensation
  
$
3,002
    
$
1,156
    
$
715
  

* During the year ended October 31, 2024, upon the departure of two executives from the Company and in accordance with the terms of their separation agreements, previously granted time-vesting restricted stock awards accelerated vesting. The Company accounted for the effects of the accelerated vesting of these stock awards as a modification, and recognized $1.2 million of incremental stock-based compensation expense for the acceleration of restricted stock awards, within selling, general and administrative expenses on the Consolidated Statements of Income for the year ended October 31, 2024.
Restricted Stock Awards and Units Activity A summary of restricted stock award activity during 2025 and the status of the Company’s restricted stock awards as of October 31, 2025, is presented below.
Restricted Stock
  
Number of
Shares
    
Weighted-Average
Fair Value at
Grant Date
  
Outstanding at October 31, 2024
    
1,423,602
    
$
23.23
  
Granted
    
583,238
      
23.42
  
Vested
    
(527,292
)
    
21.43
  
Cancelled
    
(73,876
)
    
24.14
  
Outstanding at October 31, 2025
    
1,405,672
    
$
23.93
  
Expected to vest as of October 31, 2025
    
1,303,385
    
$
23.89
  
A summary of restricted stock unit activity during 2025 and the status of the Company’s restricted stock unit awards as of October 31, 2025, is presented below.
Restricted Stock Units
  
Number of
Units
    
Weighted-Average
Fair Value at
Grant Date
  
Outstanding at October 31, 2024
    
-
    
$
-
  
Granted
    
178,166
      
21.09
  
Vested
    
(41,514
)
    
22.52
  
Cancelled
    
-
      
-
  
Outstanding at October 31, 2025
    
136,652
    
$
20.65
  
Expected to vest as of October 31, 2025
    
134,366
    
$
20.59
  
Additional Information on Restricted Stock Awards and Units
The table below presents additional information on the Company’s restricted stock awards for the three most recent fiscal years.

   
Year Ended
  
   
October 31,
    
October 31,
    
October 31,
  
 
2025
    
2024
    
2023
  
Number of shares granted
    
583,238
      
865,050
      
791,925
  
Weighted-average grant-date fair value of awards (in dollars per share)
  
$
23.42
    
$
29.50
    
$
16.84
  
Compensation costs not yet recognized
  
$
21,862
    
$
21,303
    
$
12,760
  
Weighted-average amortization period (in years)
    
2.6
      
2.8
      
2.8
  
Fair value of awards for which restrictions lapsed
  
$
11,302
    
$
9,755
    
$
6,256
  
Shares outstanding at balance sheet date
    
1,405,672
      
1,423,602
      
1,238,297
  
The table below presents additional information on the Company’s restricted stock unit awards for the three most recent fiscal years.

   
Year Ended
  
   
October 31,
    
October 31,
    
October 31,
  
 
2025
    
2024
    
2023
  
Number of units granted
    
178,166
      
-
      
-
  
Weighted-average grant-date fair value of awards (in dollars per share)
  
$
21.09
    
$
-
    
$
-
  
Compensation costs not yet recognized
  
$
2,485
    
$
-
    
$
-
  
Weighted-average amortization period (in years)
    
3.4
      
-
      
-
  
Fair value of awards for which restrictions lapsed
  
$
935
    
$
-
    
$
-
  
Restricted stock units outstanding at balance sheet date
    
136,652
      
-
      
-
  
Stock Options Activity
The table below presents a summary of stock options activity during 2025 and information on stock options outstanding at October 31, 2025.

   
Shares
    
Weighted-Average
Exercise Price
  
Weighted-Average
Remaining
Contractual Life
  
Aggregate
Intrinsic Value
  
Outstanding at October 31, 2024
    
277,625
    
$
10.39
          
Granted
    
-
    
$
-
          
Exercised
    
(162,550
)
  
$
10.45
          
Cancellations, forfeitures, and adjustments
    
(1,000
)
  
$
11.35
          
Outstanding at October 31, 2025
    
114,075
    
$
10.30
  
1.64 years
    
$
1,551
  
Exercisable at October 31, 2025
    
114,075
    
$
10.30
  
1.64 years
    
$
1,551
  
Expected to vest as of October 31, 2025
    
-
    
$
-
  
-    years
    
$
-
  
Additional Information on Stock Option Awards
The table below presents additional information on stock option awards for the three most recent fiscal years.

   
Year Ended
  
   
October 31,
    
October 31,
    
October 31,
  
 
2025
    
2024
    
2023
  
Number of options granted in period
    
-
      
-
      
-
  
Total intrinsic value of options exercised
  
$
2,127
    
$
2,981
    
$
1,654
  
Cash received from option exercises
  
$
1,698
    
$
1,888
    
$
1,101
  
Compensation cost not yet recognized
  
$
-
    
$
-
    
$
-
  
Weighted-average amortization period for cost not yet recognized (in years)
    
-
      
-
      
-